Corticosteroid-binding globulin deficiency is a rare genetic condition that affects how cortisol is carried in the blood. People with corticosteroid-binding globulin deficiency often have low total cortisol on tests but may feel well or have mild fatigue, dizziness, or pain. Features usually begin in childhood or early adulthood and tend to be lifelong, but severity varies. Most people with corticosteroid-binding globulin deficiency have a normal life span and do not need emergency treatment. Care focuses on confirming the diagnosis, treating bothersome symptoms, and avoiding unnecessary steroid therapy.
Overview
Corticosteroid-binding globulin deficiencySymptoms
Corticosteroid-binding globulin deficiency often causes no noticeable issues. When present, signs include fatigue, dizziness from low blood pressure, body aches, and poor stress tolerance. Early signs of corticosteroid-binding globulin deficiency may surface during illness, surgery, or pregnancy.
Outlook and prognosis
Most people with corticosteroid-binding globulin deficiency live full lives, especially when symptoms like fatigue, dizziness on standing, or low blood pressure are recognized and managed. Outlook varies: some feel well without treatment, while others benefit from tailored hormone support. Regular follow-up helps fine‑tune care during illness, surgery, pregnancy, or major stress.
Causes and risk factors
Corticosteroid-binding globulin deficiency usually results from inherited changes in the SERPINA6 gene. Rarely, acquired low CBG follows liver disease, protein-losing states, or severe illness. Risks include family history, parents who are related, and conditions or medicines that change liver-made proteins.
Genetic influences
Genetics play a central role in corticosteroid-binding globulin deficiency; most cases are inherited changes in the SERPINA6 gene. Variants can reduce the protein’s level or function, lowering total cortisol but often sparing free cortisol. Family patterns follow autosomal recessive or, less often, dominant inheritance.
Diagnosis
Doctors suspect it when total cortisol appears low but symptoms and stimulation tests don’t match adrenal failure. Blood tests measure CBG and free cortisol; rule out acquired causes. Genetic diagnosis of Corticosteroid-binding globulin deficiency uses SERPINA6 testing.
Treatment and drugs
Treatment for corticosteroid-binding globulin deficiency focuses on symptoms and the underlying cortisol imbalance. Many do well with observation; others need tailored hydrocortisone replacement, stress‑dose steroids during illness or surgery, and guidance to prevent low blood pressure, fatigue, or fainting. Regular follow‑up fine‑tunes dosing.
Symptoms
Most people feel well day to day, and testing often finds this condition by accident. Early features of corticosteroid-binding globulin deficiency may be absent or very subtle. Symptoms vary from person to person and can change over time. The most consistent clue is on lab tests: total cortisol runs low even though the active “free” cortisol is usually normal, so this can be mistaken for adrenal insufficiency.
Many people feel well in daily life. Corticosteroid-binding globulin deficiency is often found during testing done for another reason. Features can stay mild or absent for years.
Blood tests often show low total cortisol. Free (active) cortisol is usually normal, and the response to a standard cortisol stimulation test is typically normal too. This pattern helps distinguish it from true adrenal insufficiency.
Some people notice tiredness or low stamina, especially after stress, illness, or a poor night’s sleep. In daily routines, this might show up as small but noticeable changes. These feelings are non‑specific and can have many causes.
Lightheadedness or a “head rush” when standing up can happen at times. Blood pressure may run on the low side, and symptoms often ease when you sit or lie down. If this is frequent, checking hydration, salt intake, and other causes is important.
How people usually first notice Corticosteroid-binding globulin deficiency?
Many people first notice corticosteroid-binding globulin (CBG) deficiency when routine blood tests show very low total cortisol but they feel mostly well, or when results don’t match how they feel during stress or illness. Doctors may spot the mismatch: low total cortisol with normal or near‑normal free cortisol, leading to fatigue, dizziness, or faintness during infections, surgery, or heavy exercise, while day‑to‑day symptoms can be mild or absent. In families, the first signs of CBG deficiency can be recognized when more than one relative has puzzling “low cortisol” labs without classic adrenal insufficiency features, prompting genetic testing.
Types of Corticosteroid-binding globulin deficiency
Corticosteroid-binding globulin (CBG) deficiency has a few well-recognized variants, and the differences come down to how the gene change affects CBG levels or function. People with any variant can feel unusually tired, dizzy when standing, or achy, especially during illness or stress, even when standard cortisol tests look normal. Clinicians often describe them in these categories: complete absence, partial deficiency, or a dysfunctional form that can mislead routine lab tests. Knowing the types of CBG deficiency helps explain why symptoms vary and why some tests can be confusing.
Complete deficiency
CBG is nearly absent in the bloodstream. People often notice fatigue, muscle aches, and lightheadedness that worsen during infections or after surgery. Cortisol may measure low on some tests, yet the adrenal glands can still respond when checked carefully.
Partial deficiency
CBG levels are reduced but not zero. Symptoms can be milder and fluctuate, with stress intolerance and afternoon energy dips being common. Lab results may be borderline and require repeat or specialized testing to confirm the type of CBG deficiency.
Dysfunctional CBG
The amount of CBG may look normal, but the protein doesn’t bind cortisol properly. This can cause misleading cortisol readings and symptoms that don’t match the numbers. People may experience stress-related crashes or prolonged recovery after illness.
What genetics can tell you about symptoms
Some people with corticosteroid-binding globulin (CBG) deficiency have low total cortisol on blood tests but normal free (active) cortisol, leading to fatigue, dizziness, or nausea, especially during stress or illness. Certain SERPINA6 gene variants reduce CBG levels or function, which lowers cortisol transport and can trigger these stress-related symptoms.
Causes and risk factors
Most cases are due to changes in the SERPINA6 gene.
These changes lower the amount or the binding strength of the protein that carries cortisol in the blood.
If early symptoms of corticosteroid-binding globulin deficiency show up in several relatives, the gene change may run in the family.
Low levels of this protein can also happen with severe liver disease, kidney disorders that cause protein loss, major illness, and medicines like anabolic steroids or high-dose steroids.
Some causes are inherited, while others develop over time through lifestyle or environment.
Environmental and biological risk factors
Living with corticosteroid-binding globulin deficiency can affect how your body carries and releases cortisol, so knowing what can lower CBG matters in daily life. Understanding the environmental and biological risk factors for corticosteroid-binding globulin deficiency helps you know when to ask about testing. Genes provide a baseline, but daily surroundings add new layers. The points below highlight conditions and exposures that can reduce CBG, especially in acquired cases.
The liver makes corticosteroid-binding globulin, so serious damage can reduce its production. Advanced scarring (cirrhosis) or acute liver failure often lowers CBG levels.
Kidney disease with heavy protein loss (nephrotic syndrome) or protein-losing enteropathy can spill important proteins. CBG is one of them, so levels can drop into the range seen in corticosteroid-binding globulin deficiency.
Sepsis, major trauma, or big operations trigger inflammation that changes many blood proteins. Enzymes from white blood cells can clip CBG, so effective binding falls and corticosteroid-binding globulin deficiency may appear temporarily.
Large surface burns cause protein loss through damaged skin and drive strong inflammatory responses. Both processes can reduce CBG levels during recovery.
Genetic risk factors
Corticosteroid-binding globulin deficiency is driven by inherited changes in a single gene called SERPINA6. These changes can either lower how much of the binding protein your liver makes or weaken how tightly it carries cortisol, which can shape early symptoms of Corticosteroid-binding globulin deficiency. Carrying a genetic change doesn’t guarantee the condition will appear, and features can differ widely even within the same family. In most families, it follows an autosomal recessive pattern, meaning two SERPINA6 changes—one from each parent—are needed for the condition to show up.
SERPINA6 gene changes: Changes in the SERPINA6 gene are the direct genetic cause of Corticosteroid-binding globulin deficiency. They alter the structure or amount of the protein that transports cortisol. Different changes can lead to different lab findings and symptoms.
Autosomal recessive pattern: Most people with Corticosteroid-binding globulin deficiency have two SERPINA6 changes, one inherited from each parent. Parents typically have no symptoms. Each pregnancy of two carriers has a 25% chance of an affected child.
Carrier state: Having just one SERPINA6 change usually does not cause clear symptoms. Some carriers may have slightly lower binding protein levels on testing. Carriers can pass the change to their children.
Low production variants: Some SERPINA6 changes reduce or stop production of the binding protein. Blood tests may show very low levels of corticosteroid-binding globulin. Total cortisol can look low even when the active, free cortisol is adequate.
Weak-binding variants: Other changes leave the protein amount near normal but weaken its grip on cortisol. Binding tests can be abnormal even if the protein level is measured as normal. This pattern can still affect how cortisol is carried in the bloodstream.
Compound heterozygosity: Many individuals have two different SERPINA6 changes rather than the same one twice. The combination can shape how severe the deficiency is. Effects may differ from family to family.
Family history: Having a sibling with Corticosteroid-binding globulin deficiency strongly suggests both parents are carriers. In that situation, future children have a 25% chance of being affected and a 50% chance of being carriers. Close relatives may consider targeted genetic testing.
Variable expression: Among those with Corticosteroid-binding globulin deficiency, people with the same SERPINA6 change can have different experiences. Some have mild or no symptoms, while others notice fatigue or dizziness during illness or stress. Age and other health factors can influence how it shows up.
Lifestyle risk factors
Corticosteroid-binding globulin deficiency is usually genetic; lifestyle habits do not cause it but can influence symptom swings and day-to-day functioning. Because CBG buffers cortisol, changes in sleep, stress, or exertion can magnify peaks and dips in free cortisol. This overview focuses on how lifestyle affects Corticosteroid-binding globulin deficiency and outlines lifestyle risk factors for Corticosteroid-binding globulin deficiency. Tailoring routines may help reduce fatigue, dizziness, and post-exertional crashes.
Disrupted or short sleep can stress the HPA axis and disturb cortisol rhythms. With low CBG buffering, this may amplify morning fatigue, brain fog, or orthostatic symptoms.
Night shifts and rotating schedules misalign circadian cortisol release. In CBG deficiency, this can worsen energy variability and mood or focus problems across the day.
Prolonged or very intense training spikes cortisol demand. With reduced CBG, free cortisol surges and post-workout dips may trigger crashes, dizziness, or prolonged recovery.
Long fasting windows and very low‑carb diets raise cortisol for gluconeogenesis. In CBG deficiency, this can increase fatigue, lightheadedness, and irritability, especially late in the fast.
Risk prevention
Corticosteroid-binding globulin deficiency is inherited, so you can’t prevent the condition itself, but you can lower the chance of confusion and unnecessary treatment. Some prevention is universal, others are tailored to people with specific risks. The focus is on avoiding misread cortisol tests, planning for life events like surgery or pregnancy, and keeping care teams informed. For many, knowing early symptoms of corticosteroid-binding globulin deficiency matters less than making sure the right type of cortisol testing is used.
Low total cortisol is expected with this condition, so ask about tests that reflect free cortisol, such as salivary cortisol, when appropriate. This helps prevent confusion with adrenal insufficiency and avoids unnecessary treatment.
When you meet a new doctor, mention corticosteroid-binding globulin deficiency up front. This heads off misreading of lab results and guides the right monitoring.
Keep a note in your phone or a wallet card stating the diagnosis and preferred cortisol tests. Show it during urgent care, hospital visits, or if you cannot speak for yourself.
Before starting hormones like estrogen pills or steroid medicines, ask how they might affect cortisol readings. Adjusting plans ahead of time can reduce false alarms and extra tests.
Transmission
Corticosteroid-binding globulin deficiency isn’t contagious; you can’t catch it or pass it through everyday contact. Most often, it’s a genetic condition caused by changes in a gene called SERPINA6 and is inherited in an autosomal recessive pattern—this means each parent carries one changed copy and a child must inherit both to have the condition. Some families have milder forms when only one changed copy is present, and in rare cases a new change appears for the first time in a child. If there’s a family history, a genetics professional can explain how corticosteroid-binding globulin deficiency is inherited and discuss the chance of genetic transmission of corticosteroid-binding globulin deficiency to children.
When to test your genes
Consider genetic testing if you or close relatives have unusually low cortisol on labs, symptoms that worsen under stress, or unexpected reactions to steroids despite normal adrenal studies. Testing helps distinguish CBG deficiency from adrenal disorders and guides dosing for steroids during illness, surgery, or pregnancy. Discuss timing with your clinician if planning major procedures or family planning.
Diagnosis
Day to day, many living with corticosteroid-binding globulin (CBG) deficiency notice tiredness, lightheadedness when standing, or feeling “wiped out” after stress or illness. These symptoms can look like adrenal problems, yet routine blood cortisol can be misleading because CBG carries cortisol in the blood. Early and accurate diagnosis can help you plan ahead with confidence.
Doctors look for fatigue, dizziness on standing, poor stress tolerance, and symptoms that don’t match other common causes. They also ask about timing—such as worse symptoms during illness or after strenuous activity.
Morning total cortisol is checked, often more than once. In CBG deficiency, total cortisol can look low even when free (active) cortisol is adequate.
A blood test measures the amount of CBG protein. Low CBG supports the diagnosis and helps explain unexpectedly low total cortisol results.
Salivary cortisol or 24‑hour urine free cortisol assesses the active form not bound to proteins. Normal free cortisol with low total cortisol points toward CBG deficiency rather than adrenal failure.
Stages of Corticosteroid-binding globulin deficiency
Corticosteroid-binding globulin deficiency does not have defined progression stages. It usually reflects a stable difference in a hormone-carrying protein, so changes over time are not typical, and early symptoms of corticosteroid-binding globulin deficiency can be subtle or even absent. Different tests may be suggested to help confirm the pattern—such as measuring CBG directly, checking total and free cortisol, and sometimes genetic testing. Doctors also review medicines, liver health, and repeat bloodwork as needed, and they may monitor day-to-day issues like fatigue, dizziness, or low blood pressure during illness or stress.
Outlook and prognosis
Looking at day-to-day life, people with corticosteroid-binding globulin (CBG) deficiency often describe dips in energy, lightheaded moments when standing, or feeling unwell during illness or stress when the body needs extra cortisol on short notice. Many people ask, “What does this mean for my future?”, especially if early symptoms of CBG deficiency started in childhood or after a stressful event. Doctors call this the prognosis—a medical word for likely outcomes. In general, CBG deficiency itself is not life-shortening, and many live full lives once the pattern is recognized and managed.
The outlook is not the same for everyone, but most people do well when they learn their personal triggers and have a plan for sick days, surgery, or major stress. Some people experience mild, lingering fatigue or low blood pressure–type symptoms, while others notice few day-to-day problems between stress episodes. Serious complications are uncommon; true adrenal crisis is rare because cortisol production is often normal, but the “delivery system” is less buffered without typical binding levels. With ongoing care, many people maintain work, school, exercise, and family routines, adjusting during flares or infections.
When thinking about the future, it helps to know that long-term risks depend on how easily your body keeps cortisol in a healthy range during stress and whether you have other conditions that affect hormones or the liver. Mortality directly from CBG deficiency is not expected to be higher than the general population when stress dosing and sick-day planning are in place. Genetic testing can sometimes provide more insight into prognosis if a specific SERPINA6 gene change is identified, though not everyone with the same gene change will have the same outlook. Talk with your doctor about what your personal outlook might look like, including a plan for illnesses, travel, and procedures so you can step in early and stay ahead of symptoms.
Long-term effects
People living with corticosteroid-binding globulin deficiency often do well over the long term, and many have a normal life span. Long-term effects vary widely, with some feeling little to no day-to-day impact while others notice ongoing issues with energy or dizziness. Early features of corticosteroid-binding globulin deficiency can be subtle and easy to miss. Doctors often describe these as long-term effects or chronic outcomes rather than short-term flares.
Many remain well with no ongoing health problems. This is common in corticosteroid-binding globulin deficiency and life expectancy appears typical.
Some experience persistent tiredness and reduced stamina over years. Fatigue in corticosteroid-binding globulin deficiency can wax and wane.
Long-standing low blood pressure and lightheadedness can occur, especially on standing. For some with corticosteroid-binding globulin deficiency, dizziness tends to ease when lying down or sitting.
During illness, injury, or surgery, some may feel a reduced stress tolerance. In corticosteroid-binding globulin deficiency, total cortisol often stays low, which can complicate stress assessments even when free cortisol is adequate.
How is it to live with Corticosteroid-binding globulin deficiency?
Living with corticosteroid-binding globulin (CBG) deficiency can feel puzzling because lab tests may look unusual while day-to-day symptoms range from none at all to periods of fatigue, low energy, dizziness on standing, or feeling less resilient under stress or illness. Many find that stress, surgery, or infections hit harder, and recovery can take longer, so planning rest, staying hydrated, and keeping regular medical follow-up helps. For family, friends, and coworkers, understanding that “normal” cortisol tests can be misleading—and that support during high‑stress times matters—can ease frustration and avoid minimizing what you’re feeling. With informed clinicians and a plan for stressful events, most people adapt well and lead full, active lives.
Treatment and drugs
Treatment for corticosteroid-binding globulin deficiency focuses on easing symptoms from low free cortisol availability rather than “fixing” the binding protein itself. Many people with corticosteroid-binding globulin deficiency do not need daily medicine; when symptoms like fatigue, dizziness on standing, or low blood pressure flare, doctors may use short courses of hydrocortisone or adjust dosing during illness, surgery, or major stress. Your doctor may suggest wearing a medical alert bracelet and having a stress-dose plan for infections, vomiting, or trauma, since the body may not handle stress hormones in the usual way. Not every treatment works the same way for every person, so doses are individualized and guided by how you feel, blood pressure, sodium, and morning cortisol patterns rather than total cortisol alone. Ask your doctor about the best starting point for you.
Non-drug treatment
People living with Corticosteroid-binding globulin deficiency may notice fatigue, lightheadedness when standing, or feeling less resilient under stress, while others feel well. Early symptoms of Corticosteroid-binding globulin deficiency can be subtle, and many steps focus on comfort and avoiding confusion with adrenal problems. Non-drug treatments often lay the foundation for daily stability and help you track patterns that matter. These approaches work best alongside medical guidance about lab interpretation and when medicines are, and are not, needed.
Understanding your condition helps you avoid unnecessary restrictions or treatments. Knowing that total cortisol can look low while free cortisol is often normal may prevent mislabeling this as adrenal failure.
Keep a simple diary of fatigue, dizziness, stress, sleep, and illness days. Patterns can guide practical changes and inform your clinician about what triggers feel most relevant.
A steady sleep and wake time supports energy and stress tolerance. Aim for consistent hours and a wind-down routine, especially before busy or demanding days.
Techniques like paced breathing, gentle yoga, or mindfulness can reduce spikes in stress symptoms. Short, regular sessions often work better than occasional long ones.
Your genes may have an impact on how drugs work for you
Think of treatment choices as a set of dials your genes can nudge up or down. In corticosteroid-binding globulin deficiency, genetic differences can change steroid levels in blood and tissue, shaping dose needs, side‑effect risk, and how well certain corticosteroids work.
Pharmacological treatments
Corticosteroid-binding globulin deficiency usually doesn’t require medication because free (active) cortisol levels are typically normal, even when total cortisol looks low. Treatment focuses on avoiding unnecessary steroids and interpreting hormone tests correctly, so people aren’t labeled with adrenal insufficiency by mistake. If a separate, true adrenal hormone problem is proven, standard therapies are used for that condition. Not everyone responds to the same medication in the same way.
Hydrocortisone, prednisone, or dexamethasone are not recommended for corticosteroid-binding globulin deficiency alone. These drugs can cause side effects without helping when the issue is binding protein and not hormone production. Early symptoms of corticosteroid-binding globulin deficiency are often minimal or absent, so drug therapy is usually unnecessary.
Hydrocortisone is used only if separate adrenal insufficiency is confirmed by appropriate testing. Dosing may be increased or lowered gradually to fit stress, illness, or surgery needs.
In emergencies or major surgery, stress-dose hydrocortisone is given only when adrenal insufficiency is present or strongly suspected. For isolated corticosteroid-binding globulin deficiency, stress dosing is not needed.
Ethinyl estradiol in birth control pills raises CBG and total cortisol, but it does not treat symptoms of corticosteroid-binding globulin deficiency. It can make lab results look higher, so clinicians interpret tests with this in mind.
Genetic influences
Corticosteroid-binding globulin deficiency is most often linked to changes in a gene called SERPINA6, which makes the protein that carries cortisol in the bloodstream. In most families, this condition is inherited in an autosomal recessive pattern—both copies of the gene need to have a change for it to show up. A “carrier” means you hold the gene change but may not show symptoms. Some gene changes reduce how much of the protein is made, while others affect how well it binds cortisol; either way, blood tests can show low total cortisol even when the usable (free) cortisol is normal.
How Corticosteroid-binding globulin deficiency is inherited can influence who in a family is affected, and severity can differ from one relative to another. People with one changed copy may have lower protein levels without clear symptoms, while those with two changed copies are more likely to have noticeable effects and confusing cortisol test results. If the pattern of results or family history raises concern, genetic testing of SERPINA6 can confirm the diagnosis and help guide whether relatives should be offered testing.
Is Corticosteroid-binding globulin deficiency genetic?
Genetics play a central role in corticosteroid-binding globulin deficiency; most cases are inherited changes in the SERPINA6 gene. Variants can reduce the protein’s level or function, lowering total cortisol but often sparing free cortisol. Family patterns follow autosomal recessive or, less often, dominant inheritance.
Pharmacogenetics—how genetics influence drug effects
Treatment choices often hinge on how cortisol tests are interpreted and whether steroid therapy is truly needed. In Corticosteroid-binding globulin deficiency, changes in the SERPINA6 gene reduce the blood’s main cortisol-carrying protein, so total cortisol can read low even when the active, free cortisol is in a healthy range. Genetic testing can sometimes identify how your body handles cortisol binding, helping doctors interpret results and tailor monitoring. If steroid medicines (glucocorticoids) are required for another condition, the type and dose may be adjusted: drugs that bind strongly to this carrier, like hydrocortisone, may behave differently when the carrier is low, while options that bind less, such as dexamethasone, are less affected. Monitoring then leans more on symptoms, timing, and free or salivary cortisol rather than total cortisol alone to avoid under- or overtreatment. There’s no medication that raises this binding protein directly, so the genetic finding mainly helps prevent unnecessary steroid use and guides how any needed steroid therapy is dosed and checked over time.
Interactions with other conditions
Day to day, the biggest issue is that cortisol blood tests can be misleading when Corticosteroid-binding globulin deficiency is present, especially if another illness is going on. Doctors call it a “comorbidity” when two conditions occur together, and having CBG deficiency alongside thyroid disease, liver disease, or kidney conditions that lower blood proteins can push total cortisol readings even lower than expected. During severe infection, trauma, or surgery, certain enzymes released with inflammation can further reduce how well cortisol is carried in the blood, so lab values may look worrying even if your body has enough free (usable) cortisol. If true adrenal disorders like Addison’s disease or pituitary problems occur with CBG deficiency, symptoms can be stronger and the usual testing needs extra care to confirm low free cortisol, not just a low total number.
Hormone states that raise binding proteins—such as taking estrogen therapy—can blur the picture in Corticosteroid-binding globulin deficiency, sometimes nudging lab results toward normal while not fully correcting the binding problem. Hyperthyroidism may increase binding proteins, while advanced liver disease does the opposite; either way, results can be hard to interpret if CBG deficiency is also present. For people who live with fatigue, dizziness, or pain from other conditions, overlapping symptoms can make it harder to tell what’s due to CBG deficiency versus something else. Because of these interactions—especially the risk of mistaking CBG deficiency for adrenal insufficiency during acute illness or surgery—make sure your care team knows about the diagnosis and uses tests that assess free cortisol or dynamic function when needed.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Families and communities once noticed patterns that certain relatives bruised easily, tired quickly during illness, or felt dizzy when standing up fast. Long before hormones were measured, some people seemed unusually sensitive to stress or had symptoms that flared during infections, surgery, or late pregnancy. Doctors saw these day-to-day clues but didn’t yet have a single name to tie them together.
First described in the medical literature as low levels of a blood protein that carries cortisol, later work linked this to what we now call corticosteroid-binding globulin (CBG) deficiency. Early reports focused on lab findings—very low total cortisol in the bloodstream—yet many people felt well. This puzzled clinicians because cortisol is vital. Over time, researchers realized that when CBG is low, total cortisol looks low on tests, but the active, unbound portion can be near normal. That helped explain why some people had few symptoms while others struggled during physical stress.
From early theories to modern research, the story of corticosteroid-binding globulin deficiency is one of careful observation meeting better tools. In the 1970s and 1980s, improved hormone assays revealed that pregnancy, birth control pills, and liver conditions could raise or lower CBG. Then genetic studies identified changes in the gene called SERPINA6 that reduce CBG production or alter how well it holds cortisol. These discoveries showed that CBG deficiency can be inherited in families or acquired from other medical conditions.
Once considered rare, now recognized as more common than first thought, CBG deficiency often came to light when people were tested for suspected adrenal problems. Some were told they had “low cortisol” or even “adrenal insufficiency,” only to learn later that the issue was the carrier protein, not the adrenal glands themselves. This shift reduced unnecessary treatments and focused attention on when support is actually needed—usually during acute illness, major surgery, or severe injury.
In recent decades, awareness has grown as clinicians learned to check both total and free cortisol and to interpret results alongside CBG levels. Studies also documented features that doctors may notice: low baseline blood pressure, fatigue that worsens with infections, and symptoms that improve when the body’s stress demands are lower. Not every early description was complete, yet together they built the foundation of today’s knowledge.
Today, the history of corticosteroid-binding globulin deficiency guides practical care. Knowing the condition’s history helps explain why a normal person can have “low cortisol” on paper, why early symptoms of CBG deficiency may show up during stress, and why testing strategies changed. It also underscores a key lesson from the past: numbers matter, but context matters just as much.